NYSE:WHD
Cactus, Inc. Stock News
$50.64
-0.470 (-0.92%)
At Close: May 10, 2024
New Strong Buy Stocks for April 13th
08:17am, Wednesday, 13'th Apr 2022
LCNB, MNRL, WHD, GOGL, and CCBG have been added to the Zacks Rank #1 (Strong Buy) List on April 13th, 2022.
Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2022
02:07pm, Monday, 11'th Apr 2022 Benzinga
Upgrades
Tudor Pickering upgraded the previous rating for EQT Corp (NYSE:EQT) from Hold to Buy. EQT earned $0.41 in the fourth quarter, compared to $0.02 in the year-ago quarter. At the moment, the st
Here's Why it is Worth Investing in Cactus (WHD) Stock Now
01:42pm, Tuesday, 05'th Apr 2022 Zacks Investment Research
Cactus (WHD) has been witnessing higher sales of its wellhead and production-related equipment due to rising customer drilling activities.
Here's Why it is Worth Investing in Cactus (WHD) Stock Now
11:18am, Tuesday, 05'th Apr 2022
Cactus (WHD) has been witnessing higher sales of its wellhead and production-related equipment due to rising customer drilling activities.
Why Is Cactus, Inc. (WHD) Up 13.4% Since Last Earnings Report?
03:30pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
Cactus, Inc. (WHD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
7 “A”-Rated Stocks to Ground Your Portfolio
01:40pm, Thursday, 17'th Mar 2022
It's a good time to make sure you have "A"-rated stocks in your portfolio. Many of the ones here have my triple-"A" rating.
Cactus: Internationalization In Saudi Arabia And Oil Price Increases Are Drivers
04:35pm, Monday, 14'th Mar 2022
Cactus, Inc. designs, manufactures, and sells wellhead and pressure control equipment to large oil operators.
Citi "tactically cautious" on oilfield services given outperformance and supply chain
03:13pm, Monday, 14'th Mar 2022 Seeking Alpha
Citi analyst Scott Gruber downgraded NOV (NOV) and Cactus (WHD) to hold ahead of the open Monday, citing year-to-date outperformance and supply chain challenges. Gruber upgraded…
Benzinga's Top Ratings Upgrades, Downgrades For March 11, 2022
03:28pm, Friday, 11'th Mar 2022 Benzinga
Upgrades
According to B of A Securities, the prior rating for Sabra Health Care REIT Inc (NASDAQ:SBRA) was changed from Underperform to Neutral. In the fourth quarter, Sabra Health Care REIT showed an
Benzinga''s Top Ratings Upgrades, Downgrades For March 11, 2022
03:28pm, Friday, 11'th Mar 2022 Benzinga
Upgrades According to B of A Securities, the prior rating for Sabra Health Care REIT Inc (NASDAQ: SBRA ) was changed from Underperform to Neutral. In the fourth quarter, Sabra Health Care REIT showed an EPS of $0.39, compared to $0.42 from the year-ago quarter. The current stock performance of Sabra Health Care REIT shows a 52-week-high of $19.02 and a 52-week-low of $12.31. Moreover, at the end of the last trading period, the closing price was at $13.87. CLSA upgraded the previous rating for Gaotu Techedu Inc (NYSE: GOTU ) from Sell to Underperform. For the fourth quarter, Gaotu Techedu had an EPS of $0.19, compared to year-ago quarter EPS of $0.39. The current stock performance of Gaotu Techedu shows a 52-week-high of $93.33 and a 52-week-low of $1.39. Moreover, at the end of the last trading period, the closing price was at $1.70. B of A Securities upgraded the previous rating for XPO Logistics Inc (NYSE: XPO ) from Neutral to Buy. In the fourth quarter, XPO Logistics showed an EPS of $1.34, compared to $1.19 from the year-ago quarter.
Cactus (WHD) Rallies 9% as Q4 Earnings Surpass Estimates
01:36pm, Thursday, 03'rd Mar 2022 Zacks Investment Research
Cactus' (WHD) Q4 earnings beat estimates on increased customer drilling activity.
Cactus (WHD) Rallies 9% as Q4 Earnings Surpass Estimates
10:45am, Thursday, 03'rd Mar 2022
Cactus' (WHD) Q4 earnings beat estimates on increased customer drilling activity.
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
03:04pm, Tuesday, 01'st Mar 2022 Benzinga
Upgrades
Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71, compared to year-ago quarter
Benzinga''s Top Ratings Upgrades, Downgrades For March 1, 2022
03:04pm, Tuesday, 01'st Mar 2022 Benzinga
Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ: RVMD ) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of $50.88 and a 52-week-low of $18.07. At the end of the last trading period, Revolution Medicines closed at $18.92. According to UBS, the prior rating for Amedisys Inc (NASDAQ: AMED ) was changed from Sell to Neutral. For the fourth quarter, Amedisys had an EPS of $1.18, compared to year-ago quarter EPS of $1.49. At the moment, the stock has a 52-week-high of $292.97 and a 52-week-low of $122.12. Amedisys closed at $160.24 at the end of the last trading period. For Sunstone Hotel Investors Inc (NYSE: SHO ), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. At the moment, the stock has a 52-week-high of $13.91 and a 52-week-low of $9.93. Sunstone Hotel Invts closed at $10.58 at the end of the last trading period. Wedbush upgraded the previous rating for Logitech International SA (NASDAQ: LOGI ) from Neutral to Outperform.